Standout Papers

FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults w... 2018 2026 2020 2023 241
  1. FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia (2018)
    Aviva C. Krauss, Xin Gao et al. Clinical Cancer Research

Immediate Impact

1 by Nobel laureates 8 from Science/Nature 72 standout
Sub-graph 1 of 24

Citing Papers

Ultrasound-Based Micro-/Nanosystems for Biomedical Applications
2024 Standout
Polymeric Nanoparticles for Drug Delivery
2024 Standout
4 intermediate papers

Works of David A. Bateman being referenced

FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia
2018 Standout

Author Peers

Author Last Decade Papers Cites
David A. Bateman 70 197 22 128 80 8 369
Zhifeng Zou 24 169 4 45 104 9 310
Silvia Sommaruga 16 249 3 116 66 13 407
Nisha Sosale 74 119 4 55 58 6 303
Lucie Ahn 15 272 2 55 35 10 370
Juha Ojala 18 184 7 25 24 14 363
Ying Shen 11 184 1 68 54 10 368
Katrine Kirkeby Skeby 125 251 25 60 13 9 352
Roderick D. MacGregor 69 129 5 43 31 11 317
Noemi Moroni 27 212 6 27 38 9 364
Christine Mantis 5 254 6 46 45 12 355

All Works

Loading papers...

Rankless by CCL
2026